Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help.
Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help.
复制标题
糖肽表位通过引发 T 细胞帮助来促进 HIV-1 包膜特异性体液免疫反应。
DOI:
10.1038/s41467-020-16319-0
复制
发表时间:
2020
影响因子:
16.6
通讯作者:
Avci,FikriY
中科院分区:
文献类型:
--
作者:
Sun,Lina;Paschall,AmyV;Middleton,DustinR;Ishihara,Mayumi;Ozdilek,Ahmet;Wantuch,PaetonL;Aceil,Javid;Duke,JeremyA;LaBranche,CeliaC;Tiemeyer,Michael;Avci,FikriY
The inherent molecular complexity of human pathogens requires that mammals evolved an adaptive immune system equipped to handle presentation of non-conventional MHC ligands derived from disease-causing agents, such as HIV-1 envelope (Env) glycoprotein. Here, we report that a CD4+T cell repertoire recognizes a glycopeptide epitope on gp120 presented by MHCII pathway. This glycopeptide is strongly immunogenic in eliciting glycan-dependent cellular and humoral immune responses. The glycopeptide specific CD4+T cells display a prominent feature of Th2 and Th17 differentiation and exert high efficacy and potency to help Env trimer humoral immune responses. Glycopeptide-induced CD4+T cell response prior to Env trimer immunization elicits neutralizing antibody development and production of antibodies facilitating uptake of immunogens by antigen-presenting cells. Our identification of gp120 glycopeptide–induced, T cell–specific immune responses offers a foundation for developing future knowledge-based vaccines that elicit strong and long-lasting protective immune responses against HIV-1 infection.